Tear and aqueous humour cytokine profile in primary open-angle glaucoma

Barbara Burgos-Blasco, Beatriz Vidal-Villegas, Federico Saenz-Frances, Laura Morales-Fernandez, Lucia Perucho-Gonzalez, Julian Garcia-Feijoo, Jose M Martinez-de-la-Casa, Barbara Burgos-Blasco, Beatriz Vidal-Villegas, Federico Saenz-Frances, Laura Morales-Fernandez, Lucia Perucho-Gonzalez, Julian Garcia-Feijoo, Jose M Martinez-de-la-Casa

Abstract

Purpose: To evaluate the concentrations of pro-inflammatory cytokines in tear and aqueous humour of patients with primary open-angle glaucoma (POAG), relative to healthy controls.

Method: Tear and aqueous humour samples were collected from 29 healthy controls and 27 POAG patients. Twenty-seven inflammatory cytokines were analysed: interleukin (IL)-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL9, IL-10, IL-12, IL-13, IL-15, IL-17, eotaxin, fibroblast growth factor (FGF) basic, granulocyte colony-stimulating factor, granulocyte-monocyte colony-stimulating factor, interferon (IFN)-γ, interferon gamma-induced protein, monocyte chemo-attractant protein-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, platelet-derived growth factor, regulated on activation normal T cell expressed and secreted, tumour necrosis factor (TNF)-α and vascular endothelial growth factor (VEGF).

Results: In tear samples of glaucoma patients, an increase in IL-4, IL-12, IL-15, FGF-basic and VEGF was observed, as well as a decrease in MIP-1a relative to the control group (p < 0.05). IL-5, IL-12, IL-15, IFN-γ and MIP-1a were significantly higher in aqueous humour of glaucoma eyes (p < 0.05). A poor correlation between cytokine levels in tear and aqueous humour was observed.

Conclusion: The different profiles of inflammatory marker expression of patients with POAG and healthy controls confirm the inflammatory activity of the pathology, indicating that some of them could be used as potential biomarkers of this disease.

Keywords: cytokine; glaucoma; inflammation; primary open-angle glaucoma.

© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

References

    1. Agnifili L, Pieragostino D, Mastropasqua A, Fasanella V, Brescia L, Tosi GM & Mastropasqua L. (2015): Molecular biomarkers in primary open-angle glaucoma: From noninvasive to invasive. Prog Brain Res 221: 1-32.
    1. Benitez-del-Castillo J, Cantu-Dibildox J, Sanz-González SM, Zanón-Moreno V & Pinazo-Duran MD (2019): Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study. Eur J Ophthalmol 29: 437-443.
    1. ten Berge JC, Fazil Z, van den Born I, Wolfs RCW, Schreurs MWJ, Dik WA & Rothova A (2019): Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract. Acta Ophthalmol 97: 185-192.
    1. Chono I, Miyazaki D, Miyake H, Komatsu N, Ehara F, Nagase D & Inoue Y (2018): High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep 8: 1-11.
    1. Csősz É, Deák E, Tóth N, Traverso CE, Csutak A & Tőzsér J (2019): Comparative analysis of cytokine profiles of glaucomatous tears and aqueous humour reveals potential biomarkers for trabeculectomy complications. FEBS Open Bio 9: 1020-1028.
    1. Duvesh R, Puthuran G, Srinivasan K, Rengaraj V, Krishnadas SR, Rajendrababu S & Sundaresan P (2017): Multiplex cytokine analysis of aqueous humor from the patients with chronic primary angle closure glaucoma. Curr Eye Res 42: 1608-1613.
    1. Engel LA, Muether PS, Fauser S & Hueber A (2014): The effect of previous surgery and topical eye drops for primary open-angle glaucoma on cytokine expression in aqueous humor. Graefe's Arch Clin Exp Ophthalmol 252: 791-799.
    1. Foster PJ (2002): The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86: 238-242.
    1. Garweg JG, Zandi S, Pfister IB, Skowronska M & Gerhardt C (2017): Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma. PLoS ONE 12: 1-13.
    1. Khalef N, Labib H, Helmy H, El Hamid MA, Moemen L & Fahmy I (2017): Levels of cytokines in the aqueous humor of eyes with primary open angle glaucoma, pseudoexfoliation glaucoma and cataract. Elect Phys 9: 3833-3837.
    1. Kokubun T, Tsuda S, Kunikata H, Yasuda M, Himori N, Kunimatsu-Sanuki S & Nakazawa T (2018): Characteristic profiles of inflammatory cytokines in the aqueous humor of glaucomatous eyes. Ocul Immunol Inflammat 26: 1177-1188.
    1. Kondkar A, Sultan T, Almobarak F, Kalantan H, Al-Obeidan S & Abu-Amero K (2018): Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma. Clin Ophthalmol 12: 701-706.
    1. Martinez-de-la-Casa JM, Perez-Bartolome F, Urcelay E, Santiago JL, Moreno-Montañes J, Arriola-Villalobos P & Garcia-Feijoo J (2017): Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost. Ocular Surf 15: 723-729.
    1. Pantalon A & Constantinescu D (2019): Inflammatory model in patients with primary open angle glaucoma and diabetes. Int J Ophthalmol 12: 795-801.
    1. Pinazo-Durán MD, Zanón-Moreno V, García-Medina JJ & Gallego-Pinazo R (2013): Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma. Curr Opin Pharmacol 13: 98-107.
    1. Quigley HA (2011): Glaucoma. Lancet 377: 1367-1377.
    1. Quigley HA & Broman AT (2006): The number of people with glaucoma worldwide in 2010 and 2020. Brit J Ophthalmol 90: 262-267.
    1. Reddy S, Sahay P, Padhy D, Sarangi S, Suar M, Modak R & Rao A (2018): Tear biomarkers in latanoprost and bimatoprost treated eyes. PLoS ONE 13: e0201740.
    1. Tong Y, Zhou Y, Zheng Y, Biswal M, Zhao P & Wang Z (2017): Analyzing cytokines as biomarkers to evaluate severity of glaucoma. Int J Ophthalmol 10: 925-930.
    1. Vohra R, Tsai JC & Kolko M (2013): The Role of Inflammation in the Pathogenesis of Glaucoma. Surv Ophthalmol 58: 311-320.
    1. Weinreb RN, Aung T & Medeiros FA (2014): The pathophysiology and treatment of glaucoma: a review. JAMA 311: 1901-1911.

Source: PubMed

3
Subskrybuj